† Indicates status has not been verified in more than two years
Expression Profile of Somatostatin Receptors and Dopamine Receptor 2 in Non-functioning Pituitary Adenomas and Resistant Prolactinomas: Correlation With in Vivo Response to Pasireotide and Cabergoline
|2||Not yet recruiting||
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma